Related Experiment Video
Updated: Feb 2, 2026
03:17
Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice
Published on: March 29, 2024
1.0K
Obesity in Older Type 2 Diabetic Patients: Does Working Environment Add Vulnerability?
Maria Piedade Brandão1,2, Margarida Fonseca Cardoso3
1ESSUA-Health School, University of Aveiro, 3810-193 Aveiro, Portugal. mpiedade@ua.pt.
International Journal of Environmental Research and Public Health
|November 30, 2018
Summary
Working adults with type 2 diabetes face higher obesity risks, particularly employed women. Workplace weight surveillance is recommended for better diabetes management and health outcomes.
Area of Science:
- Endocrinology
- Public Health
- Gerontology
Background:
- Limited understanding of health management in working adults with type 2 diabetes.
- Obesity is a significant comorbidity impacting diabetes management and outcomes.
- European population data on diabetes, health behaviors, and obesity is needed.
Purpose of the Study:
- To analyze associations between health, behavioral, and sociodemographic factors and obesity in older European adults with type 2 diabetes.
- To compare characteristics of individuals with and without type 2 diabetes.
- To identify specific risk factors for obesity within the type 2 diabetes population.
Main Methods:
- Utilized data from the Survey of Health, Ageing, and Retirement in Europe (SHARE).
- Compared 1447 participants with type 2 diabetes against 28,047 without diabetes.
- Employed multilevel logistic models stratified by diabetes status to examine obesity associations.
Main Results:
- Individuals with type 2 diabetes exhibited higher physical inactivity (15.0% vs. 6.1%), more chronic diseases, functional limitations, depression, and lower well-being.
- Among those with type 2 diabetes, employed individuals (OR=1.377) and women (52% higher likelihood) were more prone to obesity.
- Higher Body Mass Index (BMI) was observed in the diabetes cohort.
Conclusions:
- Working adults with type 2 diabetes, especially women, show increased obesity risk.
- Workplace weight surveillance and tailored interventions are crucial for managing obesity in this population.
- Addressing health, behavioral, and sociodemographic factors is key for improving diabetes care and outcomes.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
5.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.0K
01:21Drug Dosing: Obese Patients
266
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
266
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
282
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
282
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
182
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
182
01:22Diabetes Mellitus: Overview and Type I Subtype
5.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.4K
01:24Obesity
1.3K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.3K